The
RxGen said it would profile in vivo brain RNA expression patterns following exposure to the toxins in an attempt to uncover critical pathways of injury and neuroprotection specific to dopaminergic neurons.
The
RxGen said it would profile in vivo brain RNA expression patterns following exposure to the toxins in an attempt to uncover critical pathways of injury and neuroprotection specific to dopaminergic neurons.